Drugs / CC-100004
last change Dec 2011 re-read 3 minutes ago

CC-100004

Developed for
skin sarcoidosis
Investigated by
Celgene Corporation · Medical University of South Carolina · University of Cincinnati

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT00794274 Nov 2008 → Dec 2011 skin sarcoidosis University of Cincinnati Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CC-100004 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00794274 ↗